Market Place
Sourcing Support
Massive Bio And Foundation Medicine Partner For Clinical Trial Optimization
13 Sep 2024 //
BUSINESSWIRE
Foundation Medicine Partners With Merus On NRG1 Fusion Tumors
28 Aug 2024 //
BUSINESSWIRE
Foundation Medicine, Repare Partner On Genomic Profiling, Companion Dx
12 Jun 2024 //
BUSINESSWIRE
Qu Biologics, Foundation Partner For Late-Stage Colorectal Cancer Care
06 Jun 2024 //
GLOBENEWSWIRE
Foundation Medicine, PMV Pharma CDx Tie-Up For p53 Reactivator
29 May 2024 //
BUSINESSWIRE
Foundation Medicine, PMV Pharma Develop CDx For p53 Reactivator
29 May 2024 //
GLOBENEWSWIRE
Foundation Medicine Asco Details: Over 20 Presentations At 2024 Meeting
24 May 2024 //
BUSINESSWIRE
Foundation Medicine Launches RNA Sequencing Test, FoundationOne®RNA, in the U.S.
21 May 2024 //
BUSINESSWIRE
Foundation Medicine Announces Details of Presentations at AACR Annual Meeting
06 Mar 2024 //
BUSINESSWIRE
Foundation Medicine Appoints Dan Malarek as Chief Executive Officer
14 Dec 2023 //
BUSINESSWIRE
AnHeart Therapeutics and Foundation Medicine Announce Collaboration
14 Dec 2023 //
BUSINESSWIRE
Foundation Medicine Announces Collaboration with Pierre Fabre Laboratories
15 Nov 2023 //
BUSINESSWIRE
Foundation Medicine Announces Participation in Cancer Institute’s Initiative
26 Oct 2023 //
BUSINESSWIRE
Foundation Medicine Announces Acceptance of 11 Abstracts at ESMO
19 Oct 2023 //
BUSINESSWIRE
FDA Approves FoundationOne®CDx as a Companion Diagnostic for Lilly’s Retevmo
09 Oct 2023 //
BUSINESSWIRE
Foundation Medicine Announces Leadership Appointments
15 Jun 2023 //
BUSINESSWIRE
FDA Approves FoundationOne Liquid CDx as a Companion Diagnostic for BRAFTOVI
09 Jun 2023 //
BUSINESSWIRE
Foundation Medicine Announces Collaboration with Merck KGaA
05 Jun 2023 //
BUSINESSWIRE
Foundation Medicine Expands Portfolio with Launch of FoundationOne®Monitor
02 Jun 2023 //
BUSINESSWIRE
Foundation and Collaborators Announce Acceptance of 21 Abstracts at ASCO
26 May 2023 //
BUSINESSWIRE
FoundationOne®Liquid CDx Receives FDA-Approval as a Companion for EXKIVITY
04 May 2023 //
BUSINESSWIRE
Roche`s Foundation Medicine lays off 135 workers
20 Apr 2023 //
ENDPTS
BMS, Foundation Medicine expand collaboration to ex-Turning Point cancer drug
11 Apr 2023 //
ENDPTS
Foundation Medicine Announces Collaboration with Karyopharm for XPOVIO
10 Jan 2023 //
BUSINESSWIRE
Foundation Medicine and Natera Announce the Launch of FoundationOneTracker
08 Jan 2023 //
BUSINESSWIRE
FoundationOne Liquid CDx Receives FDA Approval for entrectinib
04 Jan 2023 //
BUSINESSWIRE
Foundation Medicine & Relay Collaborate to Develop FoundationOne CDx
12 Sep 2022 //
BUSINESSWIRE
Foundation Medicine to Share 14 Abstracts at the 2022 ESMO
06 Sep 2022 //
BUSINESSWIRE
Flatiron Health and Genentech Demonstrates Value of Genomic Profiling
08 Aug 2022 //
BUSINESS WIRE
Roche`s entrectinib gets FDA nod for Foundation Medicine`s companion diagnostic
10 Jun 2022 //
ENDPTS
Foundation Medicine Announces Strategic Collaboration with Arvinas
05 Jun 2022 //
BUSINESSWIRE
Foundation Medicine Partners with Lung Cancer Research Foundation
03 Jun 2022 //
BUSINESSWIRE
Foundation Medicine & Collaborators to Share More Than 20 Abstracts at 2022 ASCO
26 May 2022 //
BUSINESSWIRE
Foundation Medicine and Collaborators to Share Scientific Advances at AACR22
05 Apr 2022 //
BUSINESSWIRE
FDA Approves FoundationOne CDx as a Companion Diagnostic for KEYTRUDA in MSI-H
21 Feb 2022 //
BUSINESSWIRE
Foundation Medicine Collaborates With Lilly for FoundationOne CDx & Liquid CDx
09 Feb 2022 //
BUSINESSWIRE
Roche, Foundation Medicine unveil genomic profiling kit for labs
25 Oct 2021 //
FIERCEBIOTECH
Roche`s Foundation Medicine is getting a new office in Boston`s Seaport District
23 Sep 2021 //
ENDPTS
Foundation Medicine Expands Indication for FoundationOne®Liquid CDx
16 Jul 2021 //
BUSINESS WIRE
Foundation Medicine Expands Indication for FoundationOne®Liquid CDx
15 Jul 2021 //
BUSINESS WIRE
FoundationOne®CDx Receives FDA-Approval as a Companion Diagnostic for ALUNBRIG
01 Jul 2021 //
BUSINESSWIRE
Foundation Medicine Collaborates on Research Published in NEJM
26 Jun 2021 //
BUSINESSWIRE
Foundation Medicine and InformedDNA® Collaborate to Improve
09 Mar 2021 //
BUSINESSWIRE
Foundation Medicine Expands Indication for FoundationOne®Liquid CDx
09 Nov 2020 //
FOUNDATIONMEDICINE
Foundation & Takeda Announces Collaboration To Develop Companion Diagnostics
18 Sep 2020 //
BIOSPACE
Foundation Medicine`s cancer-profiling blood test approved by FDA
28 Aug 2020 //
FIERCEBIOTECH
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy
15 Jun 2020 //
FOUNDATIONMEDICINE
Foundation Medicine and Dana-Farber Present Data at ASCO20 Showing
29 May 2020 //
BUSINESSWIRE
Foundation Medicine Receives FDA Approval for FoundationOne®CDx
20 May 2020 //
BUSINESSWIRE
Foundation Medicine Receives FDA Approval for FoundationOne®CDx
06 May 2020 //
BUSINESSWIRE
Foundation Medicine Receives FDA Approval for FoundationOne®CDx
17 Apr 2020 //
BUSINESSWIRE
